Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Hoffman La Roche

It does seem a bit absurd that we have a company where no-one has any clues what the porbable income stream will be.

Are there patents that can still be licensed or not?
By the way this stock is trading I would have to say that the general concensus is NOT!!!

I do not believe that to be the case and I believe teh company needs to giev the shareholders some clear guidance...

Charts say oversold

Share
New Message
Please login to post a reply